Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation Evaluation in High Risk Myelodysplasia: an Observational Non-interventional Study

View source ↗

Summary

An observational, non-interventional study evaluating allogeneic hematopoietic stem cell transplantation for high-risk myelodysplastic syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Saint-Louis Hospital, Paris, France | Conditions: Myelodysplasia | Status: COMPLETED